Literature DB >> 7226452

Variable effect of nifedipine on myocardial blood flow at three grades of coronary occlusion in the dog.

W S Weintraub, S Hattori, J Agarwal, M M Bodenheimer, V S Banka, R H Helfant.   

Abstract

The effect of nifedipine on myocardial blood flow at various grades of coronary stenosis is unknown, Thus 22 open-chest dogs underwent carotid to left anterior descending perfusion with flow and perfusion pressure monitoring. Grades of coronary occlusion were defined by minimum diastolic perfusion pressure. six dogs (group 1) underwent moderate occlusion to 50 to 55 mm Hg diastolic perfusion pressure; (group 2), severe occlusion to 40 mm Hg perfusion pressure; and six (group 3), more severe occlusion at 25 mm Hg. Regional myocardial blood flow was measured with radioactive microspheres before and after the intracoronary injection of 10 microgram of nifedipine. In group 1, nifedipine induced epicardial hyperemia and little change in endocardial flow in the ischemic zone. In group 2, nifedipine induced epicardial hyperemia from 1.06 to 1.39 mg/g per min, but endocardial flow decreased from 0.70 to 0.60 ml/g per min. In group 3, there was no change in blood flow. Thus the effect of nifedipine on myocardial blood flow depends on the extent of occlusion. Furthermore for certain degrees of occlusion, redistribution of blood flow from endocardium to epicardium has been shown to occur.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226452     DOI: 10.1161/01.res.48.6.937

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Nifedipine effects in severe myocardial ischaemia in the dog due to left anterior descending coronary occlusion with left circumflex coronary artery constriction.

Authors:  L Szekeres; E Udvary; A Végh
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

2.  Coronary collateral reserve during exercise induced ischemia in swine.

Authors:  F C White; D M Roth; C M Bloor
Journal:  Basic Res Cardiol       Date:  1989 Jan-Feb       Impact factor: 17.165

3.  Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepression.

Authors:  N S Cook; R P Hof
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

4.  Nicardipine for stable angina pectoris.

Authors:  S Scheidt; M M Lewinter; J Hermanovich; K Venkataraman; D Freedman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Effect of nifedipine on the myocardial and vascular response to myocardial ischemia.

Authors:  D C Homans; E Sublett; X Z Dai; R J Bache
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

6.  Influence of intracoronary nifedipine on left ventricular function, coronary vasomotility, and myocardial oxygen consumption.

Authors:  P W Serruys; T E Hooghoudt; J H Reiber; C Slager; R W Brower; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-05

7.  Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

8.  Nisoldipine and perfusion of post-stenotic myocardium in conscious pigs with different degrees of concentric stenosis.

Authors:  D J Duncker; J P Heiligers; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

Review 9.  Coronary remodeling and biomechanics: Are we going with the flow in 2020?

Authors:  Patricia E McCallinhart; Benjamin W Scandling; Aaron J Trask
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-13       Impact factor: 4.733

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.